Corient Private Wealth LP Raises Holdings in National HealthCare Corporation $NHC

Key Points

• Corient Private Wealth increased its National HealthCare stake by 158.6% in the second quarter, reaching 11,825 shares worth approximately $2.5 million. Institutional investors collectively own 56.44% of NHC.
• National HealthCare reported quarterly earnings of $1.74 per share on $408.03 million in revenue, while the stock opened at $222.86 and remains near its 12-month high.
• The company declared a quarterly dividend of $0.67 per share, equivalent to $2.68 annually and a 1.2% yield. Meanwhile, company insiders sold 12,811 shares worth approximately $2.9 million during the last quarter.

Corient Private Wealth LP grew its stake in shares of National HealthCare Corporation (NYSEAMERICAN:NHC - Free Report) by 158.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,825 shares of the company's stock after acquiring an additional 7,252 shares during the quarter. Corient Private Wealth LP owned about 0.08% of National HealthCare worth $2,499,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of NHC. BlackRock Inc. purchased a new position in shares of National HealthCare during the 2nd quarter valued at approximately $417,602,000. Morgan Stanley Institutional Investment Advisors LLC purchased a new stake in shares of National HealthCare during the 2nd quarter worth about $217,391,000. First Trust Advisors LP grew its position in shares of National HealthCare by 45.4% during the 1st quarter. First Trust Advisors LP now owns 530,302 shares of the company's stock valued at $84,689,000 after acquiring an additional 165,615 shares during the period. Bank of New York Mellon Corp purchased a new position in shares of National HealthCare in the 2nd quarter valued at about $25,854,000. Finally, Manatuck Hill Partners LLC purchased a new position in shares of National HealthCare in the 2nd quarter valued at about $12,561,000. 56.44% of the stock is owned by hedge funds and other institutional investors.

National HealthCare Trading Down 0.2%

NYSEAMERICAN NHC opened at $222.86 on Wednesday. The stock has a market capitalization of $3.49 billion, a price-to-earnings ratio of 25.07 and a beta of 0.62. The stock has a 50-day moving average of $223.64 and a 200 day moving average of $197.03. National HealthCare Corporation has a twelve month low of $116.42 and a twelve month high of $239.29.

National HealthCare (NYSEAMERICAN:NHC - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $1.74 EPS for the quarter. The company had revenue of $408.03 million for the quarter. National HealthCare had a return on equity of 10.03% and a net margin of 9.00%.

National HealthCare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.67 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $2.68 dividend on an annualized basis and a yield of 1.2%. National HealthCare's dividend payout ratio (DPR) is currently 61.89%.

Insider Activity at National HealthCare

In other news, VP Josh A. Mccreary sold 2,719 shares of National HealthCare stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $224.23, for a total value of $609,681.37. Following the sale, the vice president owned 9,979 shares in the company, valued at $2,237,591.17. This trade represents a 21.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director David R. Gifford sold 1,779 shares of National HealthCare stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $225.42, for a total transaction of $401,022.18. Following the completion of the sale, the director owned 1,030 shares in the company, valued at approximately $232,182.60. This trade represents a 63.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 12,811 shares of company stock worth $2,904,018 in the last quarter. 13.92% of the stock is owned by insiders.

National HealthCare Company Profile

National HealthCare Corporation (NHC) is a provider of post-acute health care and senior living services headquartered in Murfreesboro, Tennessee. The company operates skilled nursing and rehabilitation centers, assisted living and retirement communities, and other services designed to support patients and residents who need short-term recovery, long-term care or assistance with daily living.

NHC also provides home health, hospice and palliative care, behavioral health services, and pharmacy services.

Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Corporation (NYSEAMERICAN:NHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.